NASDAQ: $FTH Advancing Targeted Cancer Therapy There is promising news in the landscape of oncology as Faeth Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to their investigational therapy, Piktor, when used in combination with paclitaxel. What is the Piktor and Paclitaxel Combination? This clinical development program…